PRA

1. What is it? Any common name for this procedure?

Panel Reactive Antibody (PRA) is a vital laboratory immunological test used primarily in the field of organ and bone marrow transplantation. It measures the amount of anti-HLA (Human Leukocyte Antigen) antibodies present in a patient's blood serum.

The test is expressed as a percentage (ranging from $0\%$ to $100\%$). If a patient has a PRA of $50\%$, it means they have antibodies that will react against approximately $50\%$ of the general donor population. A high PRA score indicates that the patient is "sensitized," making it more difficult to find a compatible donor because their immune system is already primed to attack many foreign tissues.

Common Names:

• HLA Antibody Screen
• Sensitization Level Testing
• Anti-HLA Antibody Titers
• Virtual Crossmatch Prep

2. Common Symptoms at which one must meet the doctor

PRA testing is a diagnostic and monitoring tool rather than a treatment for physical symptoms. However, certain clinical situations and symptoms of underlying organ failure indicate the need for this procedure:

• End-Stage Organ Failure: Symptoms like chronic swelling (edema), extreme fatigue, jaundice, or shortness of breath that necessitate an organ transplant.
• History of Prior Transplants: If a patient has previously received an organ and is experiencing signs of rejection (pain at the transplant site, fever, or decreased organ function).
• Post-Transfusion Reactions: If a patient develops a fever or rash after a blood transfusion, indicating they may have developed new antibodies.
• Complications After Pregnancy: Women who have had multiple pregnancies may develop HLA antibodies (due to exposure to the father's DNA in the fetus), which can impact future transplant needs or health.

3. List of Associated Diseases

PRA testing is most commonly associated with conditions requiring long-term immunological monitoring or tissue replacement:

• Chronic Kidney Disease (CKD): Leading to end-stage renal disease (ESRD).
• Heart Failure: Requiring a cardiac transplant.
• Liver Cirrhosis: Leading to end-stage liver disease.
• Leukemia and Lymphoma: Where PRA helps determine the risk for bone marrow transplant candidates.
• Graft-versus-Host Disease (GVHD): Monitoring sensitized patients for post-transplant complications.
• Refractory Platelet Transfusion: A condition where a patient's body destroys transfused platelets because of high antibody levels.

4. List of Screening Tests for this procedure

To calculate a PRA score and identify specific antibody "targets," several advanced laboratory methods are used:

• Luminex Single Antigen Bead (SAB) Assay: The most sensitive modern method, using tiny beads coated with specific HLA proteins to identify exactly which antibodies are present.
• Flow Cytometry: A technique that uses lasers to detect if a patient's antibodies bind to donor cells.
• CDC (Complement-Dependent Cytotoxicity): An older method that measures whether a patient's serum can actually kill donor cells in a dish.
• Virtual Crossmatch: Using the identified PRA and specific antibody data to compare against a donor's HLA type in a computer database before a physical surgery is even considered.

5. Am I eligible for this procedure?

Eligibility for PRA testing is usually determined by a transplant coordinator or an immunologist. You are an ideal candidate if:

1. You are on a Transplant Waitlist: All patients waiting for a kidney, heart, lung, or liver must have their PRA checked regularly (often every 3 months).
2. You have received a Blood Transfusion: Transfusions expose you to foreign HLAs, which can raise your PRA score.
3. You have been Pregnant: Especially multiple pregnancies, as this is a common way the immune system becomes "sensitized".
4. You are Post-Transplant: To monitor for the development of "De Novo" (new) antibodies that could lead to organ rejection.

6. Pre and Post Care for this procedure

Pre-Care (Before the Blood Draw):

• Infection Check: If you have an active infection or fever, tell your doctor. Some illnesses can temporarily cause "false" spikes in antibody activity.
• Medication History: Be prepared to list any immunosuppressant medications you are currently taking, as these directly affect the test results.
• Hydration: As with any blood test, staying well-hydrated makes the draw smoother and prevents fainting.

Post-Care (After the Procedure):

• Consultation: Meet with your transplant team to discuss your percentage. If your PRA is high (e.g., above $80\%$), they may discuss Desensitization Therapy (treatments like Plasmapheresis or IVIG to lower antibody levels).
• Lifestyle Stability: Continue following your prescribed diet and medication regimen while waiting for a match.
• Regular Re-testing: Because the immune system is dynamic, you must remain "eligible" for re-testing at scheduled intervals to stay active on the transplant list.

7. Days Required for Hospitalization

PRA testing is an outpatient laboratory procedure. The physical part of the test—the blood draw—takes approximately 10 to 15 minutes.

You do not need to stay in the hospital for the results, which are typically processed in a specialized histocompatibility lab over 3 to 7 days.

Disclaimer: As per doctor’s advise the number of day’s may get modified based on the patient's clinical urgency or if the patient is currently hospitalized for organ failure stabilization.

8. Benefits of this Procedure

• Predicting Transplant Success: It provides a "safety score." A low PRA means a transplant is much more likely to be successful without immediate rejection.
• Expanding the Donor Pool: By knowing exactly which antibodies you have (via Luminex), doctors can sometimes find a donor that was previously thought to be a "mismatch" but is actually safe.
• Early Warning System: For post-transplant patients, a rising PRA can catch a rejection episode weeks before the patient feels any physical pain, allowing for early treatment.
• Fair Organ Allocation: The national transplant registry uses PRA scores to give "priority points" to highly sensitized patients, ensuring they aren't unfairly skipped just because they are harder to match.

Saving Costs and Time: It prevents "failed" transplants by ensuring the recipient's body won't immediately attack the new organ, saving the patient from unnecessary surgeries and hospital stays.